Feedback / Questions
Lynparza (olaparib) - Merck (MSD), AstraZeneca
Lynparza: Patent expiry in US in 2028
(Merck (MSD))
-
Feb 29, 2020 -
Annual report 2019: Patent expiry in China/EU in 2024 and SPC in EU until 2029; Patent expiry in Japan between 2028 -2029
Patent
http://d18rn0p25nwr6d.cloudfront.net/CIK-0000064978/75a322e0-ce26-478b-954f-5da950e9d365.pdf
Feb 29, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious